Amping up estrogen receptors in breast cancer

Breast Cancer Research

Volumn 9, Issue 4, 2007, Pages

  Fowler, Amy M ^a   Alarid, Elaine T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

BREAST TUMOR; FEMALE; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS;

EID: 40349094958     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1748     Document Type: Article

References (25)

1. Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 1896, 2:104-107.
2. Cooper AP. The Principles and Practice of Surgery. London 1836, 1.
3. Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin Cancer Res 2003, 9:1980-1989.
4. Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Janicke F, et al. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007, 39:655-660. 10.1038/ng2006, 17417639.
5. Nessling M, Richter K, Schwaenen C, Roerig P, Wrobel G, Wessendorf S, Fritz B, Bentz M, Sinn H-P, Radlwimmer B, et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res 2005, 65:439-447.
6. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 2006, 16:1465-1479. 1665631, 17142309, 10.1101/gr.5460106.
7. Schuur ER, Weigel RJ. Monoallelic amplification of estrogen receptor-α expression in breast cancer. Cancer Res 2000, 60:2598-2601.
8. Clarke RB, Howell A, Potten CS, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997, 57:4987-4991.
9. Petersen OW, Høyer PE, van Deurs B. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 1987, 47:5748-5751.
10. Fabris G, Marchetti E, Marzola A, Bagni A, Querzoli P, Nenci I. Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies. J Steroid Biochem 1987, 27:171-176. 10.1016/0022-4731(87)90307-4, 3695478.
11. Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007, 21:1132-1147. 10.1210/me.2007-0022, 17312270.
12. Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor α-positive status. Am J Pathol 2006, 168:1998-2013. 1606619, 16723714, 10.2353/ajpath.2006.051089.
13. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182. 10.1126/science.3798106, 3798106.
14. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005, 353:229-237. 10.1056/NEJMoa044383, 16034008.
15. Khan SA, Rogers MA, Obando JA, Tamsen A. Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 1994, 54:993-997.
16. Khan SA, Sachdeva A, Naim S, Meguid MM, Marx W, Simon H, Halverson JD, Numann PJ. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol. Cancer Epidemiol Biomarkers Prev 1999, 8:867-872.
17. Frech MS, Halama ED, Tilli MT, Singh B, Gunther EJ, Chodosh LA, Flaws JA, Furth PA. Deregulated estrogen receptor α expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res 2005, 65:681-685.
18. Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006, 439:168-174. 10.1038/nature04177, 16273093.
19. Jiang X, Ellison SJ, Alarid ET, Shapiro DJ. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 2007, 26:4106-4114. 10.1038/sj.onc.1210197, 17237823.
20. Fowler AM, Solodin NM, Valley CC, Alarid ET. Altered target gene regulation controlled by estrogen receptor-α concentration. Mol Endocrinol 2006, 20:291-301. 10.1210/me.2005-0288, 16179380.
21. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 58566, 11553815, 10.1073/pnas.191367098.
22. Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 2006, 24:1656-1664. 10.1200/JCO.2005.03.2755, 16505416.
23. Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de Vijver M, Deutsch P, Sachs A, et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res 2005, 65:4059-4066. 10.1158/0008-5472.CAN-04-3953, 15899795.
24. Hall FM, Mercado CL, Cangiarella J. Papillary lesions of the breast. Radiology 2007, 243:300-301.
25. Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MPA, Sibson DR, Sloane JP. Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 2000, 53:778-783. 1731078, 11064673, 10.1136/jcp.53.10.778.